Sign In
Buy ORMP
$4.07
-0.0500 (-1.21%)
At Close: Jul 31, 2026
Oramed Reports Fiscal Third Quarter 2025 Financial Results
08:56am, Monday, 17'th Nov 2025
Strong Nine-Month Performance Driven by Strategic Investment Portfolio; Total Assets Increase 42% to $220.5 Million NEW YORK , Nov. 17, 2025 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP
ORAMED PHARMACEUTICALS INC. DECLARES DIVIDEND DISTRIBUTION OF COMMON STOCK PURCHASE RIGHTS
08:50am, Monday, 17'th Nov 2025
NEW YORK , Nov. 17, 2025 /PRNewswire/ -- The Board of Directors of Oramed Pharmaceuticals Inc. (the "Company") announced today that it has unanimously adopted a Rights Agreement, dated November 17, 20
Oramed Advancing Oral Insulin Program Independently; Announces Launch of New U.S. Trial Diversified Investment Portfolio Delivers Strong Returns Company Accelerating Growth Through Strategic Partner
Oramed Pharmaceuticals Announces $36.9 Million Investment and Strategic Collaboration with Alpha Tau Medical
09:00am, Monday, 28'th Apr 2025
Oramed leverages its strategic capital markets expertise to support Alpha Tau's breakthrough cancer therapy technology Accelerating multiple late-stage cancer therapies including: US clinical trials a
JERUSALEM, April 28, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaR
Oramed Pharmaceuticals Issues Letter to Shareholders
09:00am, Tuesday, 04'th Mar 2025
Key Highlights – expected completion in YR 2025: OraTech Pharmaceuticals Inc. - A new joint venture focused on oral insulin development, with planned U.S. Phase 3 trials. Distribution of majority of
Oramed Announces Transformative Joint Venture to Accelerate Development and Commercialization of Oral Insulin
09:15am, Tuesday, 11'th Feb 2025
New Standalone Company, OraTech Pharmaceuticals Inc., to Focus on Oral Drug Delivery with Strategic Investment and Advanced Manufacturing Capabilities Oramed shareholders to receive the right to a dir
3 Micro-Cap Moonshots for Fearless Investors
03:07pm, Monday, 08'th Jul 2024
When discussing micro-cap stocks, it's important to recognize their general overlap with the world of penny stocks. These stocks trade as shares of companies with market capitalizations between $50 mi
Oramed Letter to Shareholders
08:30am, Tuesday, 20'th Feb 2024
Initiating Phase 3 oral insulin trial in the United States under a new protocol JV with Chinese Partner, HTIT Scilex Senior Secured Note PeriTech Asset Purchase & Strategic Out-licensing NEW YORK
Oramed Announces $101,875,000 Short-Term Senior Secured Note Transaction with Scilex Holding Company
06:11pm, Thursday, 21'st Sep 2023
18-month loan with interest rate of SOFR plus 8.5% Oramed receives warrants to purchase up to 17 million shares of Scilex common stock The Senior Secured Note with Scilex replaces Oramed's previously
Oramed Signs Term Sheet with HTIT to Create a Joint Venture to Advance Oral Drug Delivery Technology Globally
07:45am, Wednesday, 02'nd Aug 2023
JV will have global marketing rights to oral drug delivery technology HTIT to invest $60 million, Oramed to invest $10 million into JV HTIT to provide a supply agreement for oral insulin capsule JV to
Best Penny Stocks To Buy Today? 4 To Watch Under $5
10:46am, Thursday, 04'th May 2023
Penny stocks under $5 to watch this week. The post Best Penny Stocks To Buy Today?
Benzinga's Top Ratings Upgrades, Downgrades For January 17, 2023
03:01pm, Tuesday, 17'th Jan 2023 Benzinga
Upgrades
For Casa Systems Inc (NASDAQ:CASA), Northland Capital Markets upgraded the previous rating of Market Perform to Outperform. Casa Systems earned $0.29 in the third quarter, compared to $0.05 i
Gold Tops $1,900 After US CPI Report, S&P 500 Rises 0.5%
07:28pm, Thursday, 12'th Jan 2023 Benzinga
U.S. stocks traded higher toward the end of trading, following the release of inflation data.
The Dow traded up 0.72% to 34,219.27 while the NASDAQ rose 0.63% to 11,000.65. The S&P 500 also rose, gain
Why KNOT Offshore Partners Shares Are Trading Lower By Around 38%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
06:19pm, Thursday, 12'th Jan 2023 Benzinga
Gainers
BigBear.ai Holdings, Inc. (NYSE: BBAI) shares jumped 239% to $2.8715 after the company announced it has been awarded a multiple award $900 million Indefinite Delivery/Indefinite Quantity cont
